Maven Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Maven Securities's PFE Position: Q2 2026 in Review
Maven Securities sold out of Pfizer (PFE) in Q2 2026, closing a stake of 26,366 shares — an estimated $739K sold.
Maven Securities first reported a position in PFE in Q1 2020 and held it in 15 quarters. The position peaked at $1.5M in Q3 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Maven Securities reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Maven Securities sold 26,366 Pfizer shares in Q2 2026, an estimated $739K.
- Maven Securities first reported a position in Pfizer in Q1 2020 and held it in 15 quarters.
- Maven Securities's Pfizer position peaked at $1.5M in Q3 2022.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Maven Securities's 13F filing for Q2 2026, filed 14 Aug 2026.